Annovis Bio
ANVS
ANVS
36 hedge funds and large institutions have $22.6M invested in Annovis Bio in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
20% more funds holding
Funds holding: 30 → 36 (+6)
0.59% less ownership
Funds ownership: 12.34% → 11.75% (-0.59%)
Holders
36
Holding in Top 10
–
Calls
$3.27M
Puts
$476K
Top Buyers
| 1 | +$1.47M | |
| 2 | +$609K | |
| 3 | +$353K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$295K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$238K |
Top Sellers
| 1 | -$464K | |
| 2 | -$355K | |
| 3 | -$274K | |
| 4 |
Bank of New York Mellon
New York
|
-$244K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$215K |